IL6 and Fabry disease: Adult classic FD patients who receive ERT treatment display reduced antioxidant and increased pro-oxidant statuses and have higher levels of the pro-inflammatory cytokines tumor necrosis factor (TNF)-α and IL-6 compared with HCs (17).